Effective Pain Management During Shoulder Replacement Surgery With EXPAREL
Withdrawn before enrolling · Phase 4
Conditions studied: Pain, Postoperative, Shoulder Osteoarthritis
In brief
The purpose of this study is to examine the effectiveness of post-operative pain control of local infiltration (LIA) of EXPAREL administration to ropivacaine administered via continuous interscalene nerve block (CINB) for postoperative pain relief following shoulder replacement. Effectiveness will be measured in opioid consumption and NRS pain intensity scores from 0-4h, 4-8h, 9-12h, 13-16h, 17-20, 21-24h, 48 hours and 72 hours post-op. Patient satisfaction with pain control; patient functional outcome; adverse events related to CINB, EXPAREL administration, and opioid consumption; and pain intensity scores from the time of surgery until post-operative day 10 (+/- 5 days) will also be examined.
Key facts
- Study ID
- NCT03474510
- Run by
- TriHealth Inc.
- People needed
- 0
- Starts
- 2018-03-17
- Expected to finish
- 2019-02-01
- Last updated by the study team
- 2021-03-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Surgical candidate for primary total shoulder replacement or reverse total shoulder replacement
- Patient must be 18 years or older
- Patient must be willing and able to sign IRB approved informed consent form, and must be able to understand and agree to follow study protocol.
You may not qualify if…
- Severe bronchopulmonary disease
- Oxygen dependent
- Existing nerve injury
- BMI > 40
- Coagulation disorders
- Allergy to ropivicaine or bupivacaine
- History of drug or alcohol abuse
- Opioid use within 3 days prior to surgery
- ASA physical status > lll
- Discharge plan to Skilled nursing facility
- Pregnant women
- Non-English speaking patients
Where it is running
- Good Samarian Hospital — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.